热门资讯> 正文

Prestige Consumer Health以10.45亿美元收购Breathe Right

2026-03-20 18:33

Prestige Consumer Healthcare (PBH) to acquire the Breathe Right brand and other over-the-counter health products from Foundation Consumer Brands for $1.045 billion in cash under a definitive agreement, according to a filing.
The acquired portfolio includes Dimetapp and Anbesol with $200 million in revenue and $95 million in EBITDA. The deal is expected to close in H1 fiscal 2027.
Prestige plans to finance the acquisition with cash on hand and a new term loan.
Prestige Consumer Healthcare (PBH) rose 1.6% in premarket trading.

More on Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc. (PBH) Presents at J.P. Morgan 2026 Global Leveraged Finance Conference - Slideshow
Prestige Consumer Healthcare Inc. (PBH) Q3 2026 Earnings Call Transcript
Prestige Consumer Healthcare Inc. 2026 Q3 - Results - Earnings Call Presentation
Most oversold mid-cap healthcare stocks on Wall Street amid Middle East disruptions
Prestige Consumer Healthcare narrows fiscal 2026 revenue outlook to $1.1B while advancing Clear Eyes supply recovery

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。